Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
BOSTONRemote technologies are advancing accountable care. From the emergency room to the intensive care unit to a patients home, Banner Health is using mobile tools to make the care it delivers more efficient and less expensive, according to Chief Medical Officer Tricia Nguyen, MD.
BOSTONUnderserved communities are not benefiting as much as others from the digitization of healthcare, but initiatives are in place to spread health IT and mobile health tools have the potential to bring previously uninitiated individuals into the healthcare system, according to panelists at the 4th annual mHealth World Congress.
BOSTON--Payers are taking the lead when it comes to achieving consumer engagement with mobile health (mHealth) tools. Representatives from four health plans shared information on their mHealth tools and strategies for getting consumers to use them at the 4th annual World Health Congress.
Quantitative MR analysis revealed the presence and laterality of hippocampal atrophy in patients with temporal lobe epilepsy at rates that matched, and may exceed, expert visual interpretation, according to a study published in the August issue of Radiology.
Royal Philips Electronics plans to work with Nuvodia, a wholly owned subsidiary of Inland Imaging Investments, to bring Philips PACS to rural hospitals, smaller institutions, imaging centers, orthopedic centers and oncology practices.
Mobile phone-based software may allow physicians to manage and consult on stroke cases in real time from anywhere in the world, according to a study presented at the ninth annual meeting of the Society of NeuroInterventional Surgery in San Diego.
The FDA has cleared Covidien to sell a new bedside monitor that continuously checks oxygen saturation and pulse rate for adult, pediatric and neonatal patients. The company announced the 510(k) approval July 30, stating that its Nellcor Bedside SpO2 system with OxiMax technology helps enable clinicians to detect variations sooner than previous models.
Mobile health application (app) store Happtique is seeking public comment on a recently published draft of standards for its app certification program.
CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?
Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
